.
In the International Antigenic Typing Scheme (IATS) proposed by Liu et al. (8) for the serotyping of isolates of Pseudomonas aeruginosa, there are 17 0 antigens. The scheme is comprehensive, and at least 90% of clinical isolates, except those from patients with cystic fibrosis, can be allocated to a serotype. However, serotyping with conventional polyclonal sera has sometimes proved insufficient for maximal discrimination between strains with serotypes that occur frequently, and additional methods such as phage typing or H-antigen typing are required to distinguish between strains with the same O serotype (12) .
The discriminatory power of O serotyping of P. aeruginosa is limited by the high frequency of some serotypes, in particular, 06 and 011, and by the difficulty of distinguishing between closely related serotypes. Serotypes 02, 05, and 016 of IATS, referred to hereafter as serogroup Il, are closely related antigenically; and specific sera toward them are often difficult to prepare even after extensive absorption. Véron (18) has described four subtypes of serogroups 02 and 05; they were 02a, 02b, 05c, and 05d. Strains 02a and 05c are serotype strains 02 and 05 of the IATS (8) ; and in our laboratory we use absorbed antisera against these and subtypes 02b, 05d, and 016 in agglutination tests with clinical isolates. Cross-reactions between these types occur frequently, and some strains that react strongly with polyvalent serogroup II sera can, on subsequent testing, do not prove to be agglutinated by a specific serum (2).
Serogroup 06 accounts for approximately one-quarter of the strains identified in the United Kingdom (13) , and its frequency in other countries is comparable (7) . The subtyping of antigens for this serogroup shown to be identical by other methods presents problems in routine typing.
Monoclonal antibodies (MAbs) toward P. aeruginosa have been described by many research groups (9) . Recently Lam et al. (6) [19] ). Clinical isolates of P. aeruginosa were selected from material submitted to our laboratory for epidemiological typing, and only cultures representing distinct strains were included.
Media and growth conditions. Cultures were plated on the A agar described by King et al. (4) and incubated at 37°C for 18 h. In general, if a culture gave a typical colonial form and produced pyocyanin, it was accepted to be P. aeruginosa; atypical strains were identified as described by Phillips (11) . Strains were grown in tryptone soy broth (Oxoid Ltd., London, United Kingdom) at 37°C for 18 h and heated at 1000C for 2 h. For microtiter tray agglutination tests, the cells were centrifuged at 5,000 x g for 20 min and suspended in saline to an optical density at 600 nm of 0.5, and for the enzyme-linked immunosorbent assay (ELISA) they were suspended in 0.1 M bicarbonate buffer (pH 9.5) to an optical density at 600 nm of 0.12. 
RESULTS
Serogroup Il MAbs. Sixteen MAbs were selected from screening ELISAs with each member of the group Il complex, viz., strains 02a, 02b, 05c, 05d, and 016. All antibodies derived from mice immunized with vaccine strains 02a, 02b, and 016 were entirely specific for the homologous strain (Table 1) . Of four antibodies raised against strain 05c, two were specific and one reacted strongly with subtype strains 05d and 05c and weakly with 02b. Antibody M99 bound to all of the subtype strains except 02a. The antibody against the strain with serotype 05d (M89) was pan reactive. In immunoblots, specific MAbs reacted with high-molecular-weight components of LPS in the typical ladder profile given by LPS molecules with 0-side-chain substituents (Fig. 1) . In contrast, the panreactive antibody M89 reacted with low-molecular-weight components corresponding to the core oligosaccharide-lipid A region of the serogroup Il strains (Fig. 1) .
Fifty-five clinical strains were serotyped with polyclonal sera by agglutination, and these were then tested by both ELISA and agglutination with six representative MAbs ( 
a Agglutinated by polyvalent serum only.
over half of these reacted with M2 and M3 ( Table 3 , pattern E). Two patterns were represented by single strains only, and nine strains did not bind with any of the three MAbs. The MAb reactions were reproducible, and strains could be clearly allocated to subtypes by their patterns. There was no association between the subtypes of isolates, as determined with MAbs and their reactions with absorbed polyclonal sera. DISCUSSION There is a need for the accurate identification of minor antigens in serogroup II strains, as they have been reported to account for 10 to 20% of strains in various surveys (2, 13). Furthermore, absorbed rabbit antisera for use in agglutination tests are difficult to standardize, because batch variation in their specificity influences the reproducibility of serotyping with these reagents. MAbs appear to provide advantages over rabbit antisera in their avidity and specificity. Furthermore, they can reveal hitherto unrecognized antigenic specificities and thus are potentially more discriminating.
The MAbs described here for P. aeruginosa serogroup Il varied from being subtype specific to being pan reactive with all strains of this serogroup. They were used in agglutination tests with either heat-killed or live suspensions of bacteria and invariably gave clear, strong, and reproducible reactions. MAbs were not identical with polyclonal antisera and were clearly more sensitive and specific for the serotype epitopes than the latter, as MAbs specific for a subtype often agglutinated clinical strains that were not reactive with rabbit antisera.
In an epidemiological context, MAbs allowed the unequivocal demonstration of minor antigen types within serogroup II, although the alphabetical nomenclature for subtypes was clearly inappropriate, as MAbs often gave pattern reactions that did not necessarily correspond with a polyclonal group. The subtype-specific antibodies bound to high-molecularweight repeating units of LPS, similar to those described previously (1, 6). However, the apparent core LPS binding of the pan-reactive antibody M89 is noteworthy. Its spectrum of reactions among serogroup II strains indicated that the core LPS epitopes of this serogroup may differ from other O types of P. aeruginosa, since results of preliminary screening tests indicated that M89 does not react with the other serotype strains. This provides additional evidence that the core LPSs of P. aeruginosa are heterogeneous, as suggested by Mutharia et al. (10) .
MAbs to serotype 06 proved to be useful for the differentiation of subtypes of clinical isolates. However, because approximately half of these fell into a single subtype, the level of discrimination achieved was inferior to that obtained with serogroup II strains. Nevertheless, the rarity of some patterns of reactions suggests that they will facilitate the identification of uncommon subtypes, and further investigation of MAbs toward type 06 may reveal other specificities among clinical strains.
The IATS was proposed in recognition of the confusing diversity of serological schemes described for P. aeruginosa and the need for an internationally standard antigenic scheme. 
